Full metadata record
DC FieldValueLanguage
dc.creatorBustos, M. (Matilde)-
dc.creatorBeraza, N. (Naiara)-
dc.creatorLasarte, J.J. (Juan José)-
dc.creatorBaixeras, E. (Elena)-
dc.creatorAlzuguren, P. (Pilar)-
dc.creatorBordet, T. (Thierry)-
dc.creatorPrieto, J. (Jesús)-
dc.date.accessioned2012-01-16T08:14:35Z-
dc.date.available2012-01-16T08:14:35Z-
dc.date.issued2003-
dc.identifier.citationBustos M, Beraza N, Lasarte JJ, Baixeras E, Alzuguren P, Bordet T, et al. Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology 2003 Jul;125(1):192-201.es_ES
dc.identifier.issn0016-5085-
dc.identifier.urihttps://hdl.handle.net/10171/20422-
dc.description.abstractBACKGROUND & AIMS: Cardiotrophin-1 (CT-1) is a member of the interleukin 6 (IL-6) family of cytokines, which protect cardiac myocytes against thermal and ischemic insults. In this study, we investigated the expression of CT-1 by liver cells and its possible hepatoprotective properties. METHODS: We analyzed the production, signaling, and antiapoptotic properties of CT-1 in hepatocytes and the expression of this cytokine during liver regeneration. We also investigated whether CT-1 might exert protective effects in animal models of liver damage. RESULTS: We found that CT-1 is up-regulated during liver regeneration and exerts potent antiapoptotic effects on hepatocytic cells. Hepatocytes cultured under serum starvation or stimulated with the pro-apoptotic cytokine transforming growth factor beta (TGF-beta) produce CT-1, which behaves as an autocrine/paracrine survival factor. Treatment with an adenovirus encoding CT-1 efficiently protects rats against fulminant liver failure after subtotal hepatectomy, an intervention that causes 91% mortality in control animals whereas 54% of those receiving CT-1 gene therapy were long-term survivors. This protective effect was associated with reduced caspase-3 activity and activation of the antiapoptotic signaling cascades signal transducer and activator of transcription (Stat-3), extracellular regulated kinases (Erk) 1/2, and Akt in the remnant liver. Gene transfer of CT-1 to the liver also abrogated Concanavalin A (Con-A) liver injury and activated antiapoptotic pathways in the hepatic tissue. Similar protection was obtained by treating the animals with 5 microg of recombinant CT-1 given intravenously before Con-A administration. CONCLUSIONS: We show that CT-1 is a hepatocyte survival factor that efficiently reduces hepatocellular damage in animal models of acute liver injury. Our data point to CT-1 as a new promising hepatoprotective therapy.es_ES
dc.language.isoenges_ES
dc.publisherWb saunderses_ES
dc.rightsinfo:eu-repo/semantics/closedAccess-
dc.subjectCytokines/geneticses_ES
dc.subjectCytokines/pharmacologyes_ES
dc.subjectGene Therapyes_ES
dc.subjectLiver Failure/drug therapyes_ES
dc.titleProtection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in ratses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.driverinfo:eu-repo/semantics/articlees_ES
dc.identifier.doihttp://dx.doi.org/10.1016/S0016-5085(03)00698-Xes_ES

Files in This Item:
There are no files associated with this item.


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.